Web Access Research Portal
Research Output Details
Qiao, L and Zhou, Z and Zeng, X and Tan, C, “Cost-effectiveness of domestic PD-1 inhibitor Camrelizumab combined with chemotherapy in the first-line treatment of advanced nonsquamous non–small-cell lung cancer in China”, Frontiers in Pharmacology, 12 pp. 1-8. ISSN 1663-9812 (2021) [Refereed Article] | |
Data Type | Value |
---|---|
Type of Research | Applied Research |
Research Division | Economics |
Research Group | Econometrics |
Research Field | Economic models and forecasting |
Research Objective Division | Health |
Research Objective Group | Clinical health |
Research Objective Field | Treatment of human diseases and conditions |
Visit Item on eCite | http://ecite.utas.edu.au/147464 |
Digital Object Identifier | doi:10.3389/fphar.2021.728440 |
Scopus Source URL | View the full record on Scopus |
Scopus Citing URL | View the list of citing articles on Scopus |
Web of Science® Source URL | View the full record on Web of Science® |
Web of Science® Citing URL | View the list of citing articles on Web of Science® |
Web of Science® Related URL | View the list of related articles on Web of Science® |
Number of Times Cited | 18 |
Number of Downloads | 5 |